Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04935684
What this trial is testing

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative Syndrome+4 more
University Hospital, Clermont-Ferrand 150
Testing effectiveness (Phase 2)Study completedNCT01743131
What this trial is testing

Abatacept as GVHD Prophylaxis Phase 2

Who this might be right for
Graft vs Host DiseaseMalignancy
Boston Children's Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT07249346
What this trial is testing

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
Hannah Choe, MD 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660783
What this trial is testing

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureHemoglobinopathiesPrimary Immune Deficiency (PID)+4 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05622318
What this trial is testing

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Graft-versus-host Disease
Medical College of Wisconsin 56
Testing effectiveness (Phase 2)Ended earlyNCT01488253
What this trial is testing

Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesLeukemia, Myeloid, Chronic-Phase+1 more
The Korean Society of Blood and Marrow Transplantation 3
Testing effectiveness (Phase 2)Study completedNCT00639717
What this trial is testing

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
University of Michigan Rogel Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT01487577
What this trial is testing

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Who this might be right for
Allogeneic Blood and Marrow Transplantation (BMT)Graft Versus Host Disease
University of Pittsburgh 19
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Testing effectiveness (Phase 2)Study completedNCT03082677
What this trial is testing

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Myeloid Hematologic MalignancyLymphoid Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Testing effectiveness (Phase 2)Study completedNCT01175148
What this trial is testing

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Who this might be right for
Graft vs Host Disease
West Virginia University 60
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Study completedNCT01701245
What this trial is testing

Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care

Who this might be right for
Chronic Cluster Headache
ElectroCore INC 97
Testing effectiveness (Phase 2)UnknownNCT03297528
What this trial is testing

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Who this might be right for
Donor Lymphocyte InfusionAllogeneic Hematopoietic Stem Cell TransplantationAcute Leukemia+3 more
Peking University People's Hospital 40
Large-scale testing (Phase 3)Study completedNCT00993343
What this trial is testing

Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseSurvival
Karolinska Institutet 215
Post-approval studies (Phase 4)Study completedNCT01883180
What this trial is testing

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell TransplantationAntithymocyte GlobulinViral Infection
Nanfang Hospital, Southern Medical University 412
Testing effectiveness (Phase 2)Study completedNCT04014790
What this trial is testing

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute-graft-versus-host Disease+1 more
Regimmune Corporation 49
Large-scale testing (Phase 3)Ended earlyNCT00361413
What this trial is testing

Alefacept for Prevention of Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Versus Host Disease
Hadassah Medical Organization 26
Not applicableStudy completedNCT03716505
What this trial is testing

Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines

Who this might be right for
Migraine Disorders
ElectroCore INC 231
Next Page
64